These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 11362979)

  • 21. Update (1995) on clinical trials of antiviral therapy and prophylaxis for AIDS-related cytomegalovirus disease.
    Jacobson MA
    Scand J Infect Dis Suppl; 1995; 99():96-9. PubMed ID: 8668951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganciclovir evaluation in AIDS patients with cytomegalovirus retinitis: a European study of treatment patterns and resource utilization.
    Hardens M
    AIDS; 1996 Dec; 10 Suppl 4():S25-30. PubMed ID: 9110067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valganciclovir: new preparation. CMV retinitis: a simpler, oral treatment.
    Prescrire Int; 2003 Aug; 12(66):133-5. PubMed ID: 12906021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CMV trial enrolling.
    Vazquez E
    Posit Aware; 1997; 8(4):13. PubMed ID: 11364480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
    Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
    J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in CMV management: fomivirsen (Vitravene) approved.
    Proj Inf Perspect; 1998 Dec; (26):7. PubMed ID: 11366499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
    Murray BM; Subramaniam S
    Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients.
    Monforte V; Román A; Gavaldà J; Bravo C; Gispert P; Pahissa A; Morell F
    Transplant Proc; 2005 Nov; 37(9):4039-42. PubMed ID: 16386621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
    Mallolas J; Gatell JM; Gómez-Sirvent JL; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró JM; Lonća M; Guelar A; Soriano E
    Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of cytomegalovirus disease.
    Danner SA
    AIDS; 1995 Dec; 9 Suppl 2():S3-S8. PubMed ID: 8775800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment review.
    Treat Rev; 1995 Jan; (no 16):5. PubMed ID: 11362290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First eye implant approved.
    AIDS Alert; 1996 May; 11(5):59. PubMed ID: 11363254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized prospective trial of oral versus intravenous ganciclovir for prophylaxis of cytomegalovirus infection and disease in high-risk kidney recipients.
    Nafar M; Pezeshki ML; Farrokhi F; Einollahi B; Pour-Reza-Gholi F; Firouzan A; Farhangi S
    Transplant Proc; 2005 Sep; 37(7):3053-5. PubMed ID: 16213302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral ganciclovir shows benefit for prevention of CMV disease in liver transplant recipients.
    J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):43-4. PubMed ID: 11363747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
    Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
    Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.